Collagen Cross- Linking for Paediatric Keratoconus.

Panos GD; Kozeis N; Balidis M; Moschos MM; Hafezi F

doi:10.2174/1874364101711010211

Back

Journal article

Collagen Cross- Linking for Paediatric Keratoconus.

Panos GD Department of Ophthalmology, Ipswich Hospital NHS Trust, University of Cambridge, Ipswich, Suffolk, UK.
Kozeis N Ophthalmica Institute, Thessaloniki, Central Macedonia, Greece.
Balidis M Ophthalmica Institute, Thessaloniki, Central Macedonia, Greece.
Moschos MM Department of Ophthalmology, School of Medicine, National and Kapodistrian University of Athens, Greece.
Hafezi F ELZA Institute, Zurich, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland; Faculty of Medicine, University of South California, California, USA.

2017-09-22

Published in:

The open ophthalmology journal. - 2017

English BACKGROUND
Since the late 1990s corneal crosslinking (CXL) has been proposed as a new treatment option which can stop progression of keratoconus with promising results in adults.

OBJECTIVE
Keratoconus presents a higher rate and faster progression in paediatric patients and for this reason prompt and effective treatment is essential. Due to its success in adult keratoconus patients, CXL has been recently applied to children in order to stop or slow progression of keratoconus in paediatric patients.

CONCLUSIONS
This article will present an update of the literature on the topic of CXL in this age group.

Language